WHAT IS CAGRILINTIDE Cagrilintide is a synthetic, long-acting amylin analog peptide developed by Novo Nordisk as a potential treatment for obesity and related metabolic conditions
Side effects can depend on the research model, study design, and conditions being evaluated
GHK-Cu has been studied in clinical research showing positive effects on skin remodeling and regeneration
This ensures that every injection is tailored to your unique biological needs
Understanding Sleep Mechanisms Cortistatin Well-defined receptor pharmacology (sst1-5 plus GHSR-1a) and clear mechanism of cortical synchronization make cortistatin a more tractable research target for sleep neurobiology Human Data Availability DSIP DSIP has been administered to humans in multiple studies dating to the 1980s, providing at least some clinical data

This may be due to copper's ability to enhance the expression of metalloproteinases (MMPs).16 MMPs normally regulate the degradation of collagen, and a specific one, MMP-1, may be responsible for the initiation of collagen fragmentation.17 Supporting this, a 2024 study noted that elevated MMP-1 levels appear to contribute to aging skin and that higher MMP-1 levels in mice led to:18 The loss and fragmentation of dermal collagen fibrils Contracted fibroblast morphology Reduced collagen production Increased expression of pro-inflammatory mediators Additionally, a 2016 study found that GHK-Cu significantly increased gene expression of MMP-1 and MMP-2 at the lowest concentration, which the studys authors considered to be one of the reasons the peptide was able to increase collagen and elastin production.19 So, what this could ultimately mean is that using too much GHK-Cu (or other copper peptides) may in theory increase the skins MMP-1 concentration above the levels involved in healthy collagen production, taking it into the collagen fragmentation and breakdown territory seen in older skin with naturally higher MMP-1 levels
